Point72 Asset Management
TARO

Point72 Asset Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Point72 Asset Management’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-21,900
Closed -$1.61M – 1215
2021
Q1 		$1.61M Sell
21,900
-20,100
-48% -$1.53M 0.01% 757
2020
Q4 		$3.08M Buy
+42,000
New +$2.7M 0.02% 666

Other funds holding TARO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management's TARO Position: Q2 2021 in Review

Point72 Asset Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2021, closing a stake of 21,900 shares — an estimated $1.61M sold.

Point72 Asset Management first reported a position in TARO in Q4 2020 and held it in 2 quarters. The position peaked at $3.08M in Q4 2020. 76 funds tracked by Wall St. Rank hold TARO as of Q2 2021.

  • Point72 Asset Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2021 after selling out during the quarter.
  • Point72 Asset Management sold 21,900 Taro Pharmaceutical Industries Ltd. shares in Q2 2021, an estimated $1.61M.
  • Point72 Asset Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2020 and held it in 2 quarters.
  • Point72 Asset Management's Taro Pharmaceutical Industries Ltd. position peaked at $3.08M in Q4 2020.
  • 76 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2021.

Based on Point72 Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.